These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 21199169

  • 1. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
    Suganuma M, Saha A, Fujiki H.
    Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
    Fujiki H, Sueoka E, Watanabe T, Suganuma M.
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.
    Fujiki H, Suganuma M.
    Cancer Lett; 2012 Nov 28; 324(2):119-25. PubMed ID: 22626556
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
    Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H.
    Cancer Res; 1999 Jan 01; 59(1):44-7. PubMed ID: 9892181
    [Abstract] [Full Text] [Related]

  • 7. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
    Saha A, Kuzuhara T, Echigo N, Suganuma M, Fujiki H.
    Cancer Prev Res (Phila); 2010 Aug 01; 3(8):953-62. PubMed ID: 20606042
    [Abstract] [Full Text] [Related]

  • 8. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
    Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE, Ellis LM.
    Br J Cancer; 2001 Mar 23; 84(6):844-50. PubMed ID: 11259102
    [Abstract] [Full Text] [Related]

  • 9. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R, Sasaki K, Yoshida K.
    Toxicol In Vitro; 2009 Aug 23; 23(5):834-9. PubMed ID: 19406223
    [Abstract] [Full Text] [Related]

  • 10. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
    Azam S, Hadi N, Khan NU, Hadi SM.
    Toxicol In Vitro; 2004 Oct 23; 18(5):555-61. PubMed ID: 15251172
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Down-regulation of histone deacetylase 4, -5 and -6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin.
    Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, Shudo K, Fujiki H, Suganuma M.
    J Nutr Biochem; 2017 Apr 23; 42():7-16. PubMed ID: 28103535
    [Abstract] [Full Text] [Related]

  • 13. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ.
    Mol Carcinog; 2006 May 23; 45(5):309-19. PubMed ID: 16508969
    [Abstract] [Full Text] [Related]

  • 14. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, Lee IP, Kim SH, Kim CK, Ahn WS.
    Gynecol Oncol; 2004 Sep 23; 94(3):760-8. PubMed ID: 15350370
    [Abstract] [Full Text] [Related]

  • 15. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
    Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H.
    Int J Oncol; 2002 Jun 23; 20(6):1233-9. PubMed ID: 12012004
    [Abstract] [Full Text] [Related]

  • 16. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 17. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
    Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ.
    Int J Oncol; 2010 Jul 08; 37(1):111-23. PubMed ID: 20514403
    [Abstract] [Full Text] [Related]

  • 18. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N, Cheng P, Mukhtar H.
    Biochem Biophys Res Commun; 2000 Aug 28; 275(2):328-34. PubMed ID: 10964666
    [Abstract] [Full Text] [Related]

  • 19. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 20. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E, Dupertuis YM, Miralbell R, Pichard C.
    Clin Nutr; 2013 Dec 01; 32(6):894-903. PubMed ID: 23582951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.